MCAM and neoplasm: Our study confirmed the antiproliferative effect of MCAM silencing in tumor cells that have high-level (B16F10 melanoma) and low-level (TS/A carcinoma) expressions of MCAM, since silencing MCAM after GET reduced cell survival (the clonogenicity) by 85% in melanoma and 43% carcinoma.